Skip to main content
. 2020 Feb 22;37(4):1479–1495. doi: 10.1007/s12325-020-01258-5

Table 1.

Attributes and levels used in the discrete choice experiment

Attribute Level 1 Level 2 Level 3 Level 4
Time with optimal QoL 10 years 7 years 5 years 2 years
Substantial improvement of RA symptoms 9 out of 10 patients 7 out of 10 patients 5 out of 10 patients 3 out of 10 patients
Onset of treatment action 7 days 15 days 1 month 3 months
Severe adverse events 1 out of 100 patients 5 out of 100 patients
Mild adverse events 10 out of 100 patients 30 out of 100 patients
Mode of administration Daily oral Weekly subcutaneous Monthly subcutaneous Monthly intravenous
Additional cost/month for treatment 0 10 20 50

QoL quality of life, RA rheumatoid arthritis